Published in Am J Clin Nutr on December 01, 2000
Glycine N -methyltransferase deficiency: a new patient with a novel mutation. J Inherit Metab Dis (2003) 1.44
S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc Natl Acad Sci U S A (2004) 1.32
Plasma homocysteine in adolescents depends on the interaction between methylenetetrahydrofolate reductase genotype, lipids and folate: a seroepidemiological study. Nutr Metab (Lond) (2009) 0.78
Combined effect of folate and adiposity on homocysteine in children at three years of age. Nutr Res Pract (2015) 0.75
Connective tissue: Vascular and hematological (blood) support. J Chiropr Med (2003) 0.75
Elevated plasma homocysteine in obese schoolchildren with early atherosclerosis. Eur J Pediatr (2005) 0.75
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 7.30
Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet (1995) 5.58
A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab (1998) 5.06
Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation (1996) 4.62
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res (1991) 3.89
Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med (1999) 3.63
Fatal enterovirus 71 encephalomyelitis. J Pediatr (1998) 3.39
Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res (1997) 3.36
Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet (2001) 2.93
Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet (1996) 2.68
Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet (1994) 2.50
The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol (1999) 2.43
Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol (2001) 2.43
Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol (1994) 2.27
Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol (2001) 2.19
Behavioural problems in children who weigh 1000 g or less at birth in four countries. Lancet (2001) 2.08
A systematic review of the effectiveness of health service interventions aimed at reducing inequalities in health. J Health Serv Res Policy (1996) 2.08
The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis (2001) 2.06
Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation (1996) 2.06
Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet (1999) 2.02
The heart and the atrial natriuretic factor. Endocr Rev (1985) 1.99
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest (2000) 1.98
Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci U S A (2001) 1.91
Do you see what I see? Weight status misperception and exposure to obesity among children and adolescents. Int J Obes (Lond) (2008) 1.90
Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada. Can J Cardiol (1998) 1.88
Population history and its impact on medical genetics in Quebec. Clin Genet (2005) 1.85
THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE. J Clin Invest (1961) 1.84
Cystinuria subtype and the risk of nephrolithiasis. Kidney Int (1998) 1.81
Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell (1990) 1.80
Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol (1998) 1.80
Gene deletion and restriction fragment length polymorphisms at the human ornithine transcarbamylase locus. Nature (1985) 1.77
A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab (1999) 1.75
Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet (1996) 1.74
Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation (2001) 1.71
Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis (2001) 1.69
5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet (1996) 1.68
Homozygous familial hypercholesterolemia among French Canadians in Québec Province. Arteriosclerosis (1989) 1.68
Vascular calcifications in homozygote familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2008) 1.67
Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr (1996) 1.67
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatr Scand (2005) 1.67
Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int (1998) 1.64
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus (1995) 1.63
[Leishmaniasis and human immunodeficiency virus infections]. Presse Med (1995) 1.61
Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr (1998) 1.60
Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun (1984) 1.59
Campylobacter enteritis and erythema nodosum. Lancet (1982) 1.59
Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet (2000) 1.57
Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet (1999) 1.57
A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet (1993) 1.57
Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res (2001) 1.56
Angiotensin-forming enzyme in brain tissue. Science (1971) 1.55
Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR) Mamm Genome (1998) 1.49
Neurologic crises in hereditary tyrosinemia. N Engl J Med (1990) 1.48
Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am J Pharmacogenomics (2001) 1.46
Percutaneous transluminal angioplasty in coronary-internal thoracic-subclavian steal syndrome. Can J Cardiol (1997) 1.46
Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr (1995) 1.46
Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients. Lupus (2008) 1.45
Metabolic rate, not percent dehydration, predicts rectal temperature in marathon runners. Med Sci Sports Exerc (1991) 1.45
Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics. Psychopathology (2000) 1.44
Glycine N-methyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninaemia. J Inherit Metab Dis (2001) 1.42
Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med (2001) 1.41
Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy. Am J Cardiol (1991) 1.41
Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species. J Histochem Cytochem (1985) 1.41
Primary structure of a human trifunctional enzyme. Isolation of a cDNA encoding methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase. J Biol Chem (1988) 1.40
Novel PKU mutation on haplotype 2 in French-Canadians. Am J Hum Genet (1989) 1.40
Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean. Am J Hum Genet (1993) 1.40
Focal segmental glomerulosclerosis (FSG) 20 years later. From toddler to grown up. Clin Nephrol (1993) 1.39
Medical aspects of ketone body metabolism. Clin Invest Med (1995) 1.37
Has the CMA become "big business"? CMAJ (1990) 1.37
Production of insulin resistance by hyperinsulinaemia in man. Diabetologia (1985) 1.36
Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am J Med Genet (1998) 1.33
Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J Pediatr (1999) 1.31
A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (1999) 1.31
Perioperative anaphylaxis. Med Clin North Am (2010) 1.29
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation (2002) 1.29
Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations. Am J Hum Genet (1990) 1.28
Amino acid sequence of homologous rat atrial peptides: natriuretic activity of native and synthetic forms. Proc Natl Acad Sci U S A (1984) 1.28
Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet (1995) 1.28
Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf) (2003) 1.27
Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry (1985) 1.26
Atrial natriuretic factor is a circulating hormone. Biochem Biophys Res Commun (1984) 1.26
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol (1997) 1.26
Renin-aldosterone system in Parkinson's disease. Science (1969) 1.26
Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology (1984) 1.22
Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is caused by mutations in a gene encoding a mitochondrial ornithine transporter. Nat Genet (1999) 1.21
Isolation of Campylobacter hyointestinalis from pigs in the United Kingdom. Vet Rec (1984) 1.21
Mycoplasma pneumoniae infections in a rural setting in Canada. CMAJ (1987) 1.20
Molecular genetics of cystinuria: mutation analysis of SLC3A1 and evidence for another gene in type I (silent) phenotype. Kidney Int (1998) 1.20
The atrial natriuretic factor: its physiology and biochemistry. Rev Physiol Biochem Pharmacol (1988) 1.20
Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev (2010) 1.19
Physical activity vs. sedentary time: independent associations with adiposity in children. Pediatr Obes (2012) 1.19
Role of the adrenal cortex and sodium in the pathogenesis of human hypertension. Can Med Assoc J (1978) 1.19
Genomic, protein homogeneity and antigenic variability of Mycoplasma agalactiae. Vet Microbiol (1996) 1.19
Immunocytochemical localization of atrial natriuretic factor in the heart and salivary glands. Histochemistry (1984) 1.19
Deletion proximal to DXS68 locus (L1 probe site) in a boy with Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal hypoplasia. Hum Genet (1988) 1.18
Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following Fursemide administration. Can J Physiol Pharmacol (1968) 1.18
Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation (1996) 1.16